Results
Nu-Med Plus Inc.
11/02/2026 | Press release | Distributed by Public on 11/02/2026 15:51
Corporate Action, Amendments to Bylaws, Proxy Statement (Form 8-K)
Item 3.03. Material Modification to Rights of Security Holders.
The information in
Item 5.03
of this Current Report on Form 8-K is incorporated by reference into this
Item 3.03
, to the extent applicable.
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On November 2, 2026, the Board of Directors (the "
Board
") of Nu-Med Plus, Inc. (the "
Company
"), amended the Company's Bylaws, effective as of the same date, to add a new section thereof, confirming that pursuant to Utah Code Ann. § 16-10a-1533.5 (or any successor statute), any transfer of the Company's domicile to, or domestication of the Company in, a jurisdiction other than the State of Utah is required to be approved by the affirmative vote of a majority of the votes cast by the shares entitled to vote thereon, present in person or represented by proxy at a meeting at which a quorum is present.
The foregoing summary of the Bylaws amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Bylaws amendment, a copy of which is filed as
Exhibit 3.1
to this Current Report on Form 8-K (this "
Current Report
") and is incorporated in this
Item 5.03
by reference.
Item 5.08. Shareholder Director Nominations.
The information in
Item 8.01
of this Current Report on Form 8-K is incorporated by reference into this
Item 5.08
, to the extent applicable.
Nu-Med Plus Inc. published this content on November 02, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 02, 2026 at 21:51 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]